These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 35509101)

  • 21. METTL3 promotes colorectal cancer metastasis by promoting the maturation of pri-microRNA-196b.
    Huang L; Liang D; Zhang Y; Chen X; Chen J; Wen C; Liu H; Yang X; Yang X; Lin S
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5095-5108. PubMed ID: 36348020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition.
    Zhu Y; Peng X; Zhou Q; Tan L; Zhang C; Lin S; Long M
    Cell Death Dis; 2022 Apr; 13(4):358. PubMed ID: 35436987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification.
    Hou P; Meng S; Li M; Lin T; Chu S; Li Z; Zheng J; Gu Y; Bai J
    J Exp Clin Cancer Res; 2021 Feb; 40(1):52. PubMed ID: 33526059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KIAA1429 promotes gastric cancer progression by destabilizing RASD1 mRNA in an m
    Ren M; Pan H; Zhou X; Yu M; Ji F
    J Transl Med; 2024 Jun; 22(1):584. PubMed ID: 38902717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway.
    Peng W; Li J; Chen R; Gu Q; Yang P; Qian W; Ji D; Wang Q; Zhang Z; Tang J; Sun Y
    J Exp Clin Cancer Res; 2019 Sep; 38(1):393. PubMed ID: 31492150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. m
    Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
    Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methyltransferase-like 3 promotes cervical cancer metastasis by enhancing cathepsin L mRNA stability in an N6-methyladenosine-dependent manner.
    Liu P; Ju M; Zheng X; Jiang Y; Yu X; Pan B; Luo R; Jia W; Zheng M
    Cancer Sci; 2023 Mar; 114(3):837-854. PubMed ID: 36382580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. m6A Methyltransferase, WTAP, Promotes Cancer Progression in Laryngeal Squamous Cell Carcinoma by Regulating PLAU Stability.
    Liu F; Xia F; Wang C; Ren R; Zhang M; Gong J; Zhang Q
    Ann Clin Lab Sci; 2023 Mar; 53(2):293-302. PubMed ID: 37094860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization.
    Chen C; Yuan W; Zhou Q; Shao B; Guo Y; Wang W; Yang S; Guo Y; Zhao L; Dang Q; Yang X; Wang G; Kang Q; Ji Z; Liu J; Sun Z
    Theranostics; 2021; 11(9):4298-4315. PubMed ID: 33754062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
    Wei K; Gao Y; Wang B; Qu YX
    Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. METTL3-mediated m6A modification of CDCA7 mRNA promotes COAD progression.
    Hua M; Zhai X; Chen Y; Yin D
    Pathol Res Pract; 2024 Aug; 260():155437. PubMed ID: 38959625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.
    Meng QZ; Cong CH; Li XJ; Zhu F; Zhao X; Chen FW
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4328-4336. PubMed ID: 32373970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms.
    He P; Liu X; Yu G; Wang Y; Wang S; Liu J; An Y
    Mol Cell Biochem; 2024 Jul; 479(7):1707-1720. PubMed ID: 38822192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2.
    Huang X; Yang Z; Li Y; Long X
    Ann Hematol; 2023 Jul; 102(7):1801-1810. PubMed ID: 37222774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA linc00659 promotes tumour progression by regulating FZD6/Wnt/β-catenin signalling pathway in colorectal cancer via m6A reader IGF2BP1.
    Xu S; Liu Z; Luo Q; Chang L; Ding J; Xiao Y; Zhang Y; Zhou G; Wang K
    J Gene Med; 2024 Jan; 26(1):e3636. PubMed ID: 38009760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. METTL3 promotes proliferation of goat endometrial epithelial cells by regulating CTGF in an m6A-dependent manner†.
    Sun Y; Zhang XC; Li MD; Bu LG; Wang B; Li TY; Ding NZ; Ni H
    Biol Reprod; 2023 Jun; 108(6):902-911. PubMed ID: 36917263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
    Ni Z; Sun P; Zheng J; Wu M; Yang C; Cheng M; Yin M; Cui C; Wang G; Yuan L; Gao Q; Li Y
    Cancer Res; 2022 May; 82(9):1789-1802. PubMed ID: 35502544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer.
    Yoshino H; Enokida H; Chiyomaru T; Tatarano S; Hidaka H; Yamasaki T; Gotannda T; Tachiwada T; Nohata N; Yamane T; Seki N; Nakagawa M
    Biochem Biophys Res Commun; 2012 Jan; 417(1):588-93. PubMed ID: 22178073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.